Ask me later
Ask me later
How likely are you to recommend Redeye to a friend or colleague?
1
2
3
4
5
6
7
8
9
10
Not likely
Very likely
Not likely
1
2
3
4
5
6
7
8
9
10
Very likely
Thanks again for rating us!
Egetis Therapeutics: Infocus interview with CEO Nicklas Westerholm at Redeye Life Science Day 2022
November 27 2022